Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024) Certified by Founder
Lodge
MBrace Therapeutics
start up
United States
- San Diego, California
- 15/11/2023
- Series B
- $85,000,000
MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.
- Industry Biotechnology Research
- Website https://mbracetrx.com/
- LinkedIn https://www.linkedin.com/company/mbrace-therapeutics/about/
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
KeySavvy | $4,250,000 | (Nov 22, 2024)
Magma Math | $40,000,000 | (Nov 21, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)